Matches in SemOpenAlex for { <https://semopenalex.org/work/W2580497094> ?p ?o ?g. }
- W2580497094 endingPage "304" @default.
- W2580497094 startingPage "295" @default.
- W2580497094 abstract "Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy Othman Al-Sawaf, Kirsten Fischer, Anja Engelke, Natali Pflug, Michael Hallek, Valentin Goede German CLL Study Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany Abstract: For decades, treatment of chronic lymphocytic leukemia (CLL) has been based on chemotherapy. This changed when the first CD20 antibody rituximab was introduced. Since 2008, the combination of chemotherapy and CD20 antibodies has become the standard of care for most patients, and a significant fraction of patients had very long-lasting remissions after chemoimmunotherapy. Despite the improvement of response rates and overall survival (OS) by the use of chemoimmunotherapy, most CLL patients will relapse eventually. One approach to achieve more durable responses was the development of obinutuzumab (GA101), a new type of CD20 antibody that has unique molecular and functional characteristics. Obinutuzumab is a type II fully humanized CD20 antibody that binds to a partly different epitope of the CD20 protein than rituximab and due to its glycoengineered design induces greater antibody-dependent cell-mediated cytotoxicity (ADCC). Initial preclinical observations of a more effective B-cell depletion have been successfully reproduced in clinical trials with CLL patients. This review summarizes results of preclinical as well as clinical studies with obinutuzumab and provides an outlook on its future role in the therapy of CLL. Keywords: chronic lymphocytic leukemia, GA101, obinutuzumab, CD20 antibody" @default.
- W2580497094 created "2017-02-03" @default.
- W2580497094 creator A5052452632 @default.
- W2580497094 creator A5061682665 @default.
- W2580497094 creator A5066245661 @default.
- W2580497094 creator A5072016915 @default.
- W2580497094 creator A5076077834 @default.
- W2580497094 creator A5085633786 @default.
- W2580497094 date "2017-01-01" @default.
- W2580497094 modified "2023-10-17" @default.
- W2580497094 title "Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy" @default.
- W2580497094 cites W1509374036 @default.
- W2580497094 cites W1593858110 @default.
- W2580497094 cites W1843407789 @default.
- W2580497094 cites W1893837372 @default.
- W2580497094 cites W1897592311 @default.
- W2580497094 cites W1935886040 @default.
- W2580497094 cites W1942856476 @default.
- W2580497094 cites W1964486259 @default.
- W2580497094 cites W1969824500 @default.
- W2580497094 cites W1981177563 @default.
- W2580497094 cites W1982952278 @default.
- W2580497094 cites W1983395516 @default.
- W2580497094 cites W1986197388 @default.
- W2580497094 cites W1986924929 @default.
- W2580497094 cites W2010329820 @default.
- W2580497094 cites W2021628104 @default.
- W2580497094 cites W2027374210 @default.
- W2580497094 cites W2029850226 @default.
- W2580497094 cites W2029915215 @default.
- W2580497094 cites W2042725832 @default.
- W2580497094 cites W2043946207 @default.
- W2580497094 cites W2044360617 @default.
- W2580497094 cites W2066564017 @default.
- W2580497094 cites W2074143045 @default.
- W2580497094 cites W2079579628 @default.
- W2580497094 cites W2083435401 @default.
- W2580497094 cites W2086296392 @default.
- W2580497094 cites W2091057822 @default.
- W2580497094 cites W2099692383 @default.
- W2580497094 cites W2109687784 @default.
- W2580497094 cites W2120319857 @default.
- W2580497094 cites W2121227413 @default.
- W2580497094 cites W2122725450 @default.
- W2580497094 cites W2131823788 @default.
- W2580497094 cites W2131909425 @default.
- W2580497094 cites W2135802989 @default.
- W2580497094 cites W2140606816 @default.
- W2580497094 cites W2143715586 @default.
- W2580497094 cites W2143901303 @default.
- W2580497094 cites W2147047596 @default.
- W2580497094 cites W2150487985 @default.
- W2580497094 cites W2152155460 @default.
- W2580497094 cites W2159970259 @default.
- W2580497094 cites W2168874755 @default.
- W2580497094 cites W2173371792 @default.
- W2580497094 cites W2207800748 @default.
- W2580497094 cites W2284975440 @default.
- W2580497094 cites W2295348655 @default.
- W2580497094 cites W2297912693 @default.
- W2580497094 cites W2322176051 @default.
- W2580497094 cites W2337485820 @default.
- W2580497094 cites W2396328865 @default.
- W2580497094 cites W2469109222 @default.
- W2580497094 doi "https://doi.org/10.2147/dddt.s104869" @default.
- W2580497094 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5279834" @default.
- W2580497094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28182141" @default.
- W2580497094 hasPublicationYear "2017" @default.
- W2580497094 type Work @default.
- W2580497094 sameAs 2580497094 @default.
- W2580497094 citedByCount "13" @default.
- W2580497094 countsByYear W25804970942017 @default.
- W2580497094 countsByYear W25804970942018 @default.
- W2580497094 countsByYear W25804970942020 @default.
- W2580497094 countsByYear W25804970942021 @default.
- W2580497094 countsByYear W25804970942023 @default.
- W2580497094 crossrefType "journal-article" @default.
- W2580497094 hasAuthorship W2580497094A5052452632 @default.
- W2580497094 hasAuthorship W2580497094A5061682665 @default.
- W2580497094 hasAuthorship W2580497094A5066245661 @default.
- W2580497094 hasAuthorship W2580497094A5072016915 @default.
- W2580497094 hasAuthorship W2580497094A5076077834 @default.
- W2580497094 hasAuthorship W2580497094A5085633786 @default.
- W2580497094 hasBestOaLocation W25804970941 @default.
- W2580497094 hasConcept C126322002 @default.
- W2580497094 hasConcept C143998085 @default.
- W2580497094 hasConcept C159654299 @default.
- W2580497094 hasConcept C18031839 @default.
- W2580497094 hasConcept C203014093 @default.
- W2580497094 hasConcept C2777607594 @default.
- W2580497094 hasConcept C2777938653 @default.
- W2580497094 hasConcept C2778461978 @default.
- W2580497094 hasConcept C2778714382 @default.
- W2580497094 hasConcept C2780653079 @default.
- W2580497094 hasConcept C2780790343 @default.
- W2580497094 hasConcept C40677261 @default.
- W2580497094 hasConcept C542903549 @default.
- W2580497094 hasConcept C71924100 @default.